))
S1E1: Developing a Domestic UK Cannabis Market - Eric Bystrom, CEO of Cellen Therapeutics - Grow Conversations
Manage episode 372179332 series 3496434
Content provided by Grow Conversations. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Grow Conversations or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Alex Fraser, Patient Access Lead at GROW Pharma, speaks to Eric Bystrom, CEO of Cellen Therapeutics, an independent UK based company run by NHS consultants who are on a mission to break down the barriers to accessing medical cannabis.
Discussing a range of topics including
- Issues with patient access
- Developing bespoke medicines|
- Nuances of developing cannabis medicines for the UK
- Project Twenty21?
- Real world evidence vs RCT’s
And much much more.
Find our more about Cellen at www.cellenhealth.com
Follow Eric on www.twitter.com/e_bystrom
Follow Alex on www.twitter.com/AlexFraserCanna
-----------------------------------------------------------------------------------------------------
Grow Conversations is your window into the world of medical cannabis.
Brought to you by Grow Pharma - Unlocking the Medical Potential of Cannabis
www.Grow-Pharma.com
www.facebook.com/GrowPharmaUK
www.twitter.com/GrowPharmaUK
www.linkedin.com/company/growpharmauk
https://www.instagram.com/grow_pharma
https://www.tiktok.com/@growgroupplc
Stay tuned for the next episode coming soon!
14 episodes
Share
